Neuroleptic Malignant Syndrome Induced by Lamotrigine
Authors:
- Norio Yasui-FurukoriNYNorio Yasui-Furukori
- Kojiro HashimotoKHKojiro Hashimoto
- Norio SugawaraNSNorio Sugawara
- 1 July 2013
- journal article
- case report
- Published by Wolters Kluwer Health in Clinical Neuropharmacology
- Vol. 36 (4) , 131-132
Abstract
This case report describes a 54-year-old man with bipolar I disorder who was treated with aripiprazole (ARP) and lithium. The patient was admitted to our hospital because of aggravation of depressive symptoms, and treatment with lamotrigine (LTG) was initiated. Two weeks after admission, we discontinued administration of ARP after the appearance of a tremor. Three weeks after discontinuing ARP, the patient developed a high fever, rigidity of the arms, diarrhea, dysphagia, and diaphoresis. We suspected these symptoms were consistent with neuroleptic malignant syndrome and therefore removed the application of LTG. After 2 days, most of the patient's symptoms and blood results had improved, leading us to conclude that the LTG treatment had induced neuroleptic malignant syndrome. Thus, the purpose of this case report was to warn psychiatrists against therapy with LTG, as it may be conducive to neuroleptic malignant syndrome.Keywords
This publication has 12 references indexed in Scilit:
- Neuroleptic malignant syndrome: a neuroimmunologic hypothesisCanadian Medical Association Journal, 2010
- Neuroleptic malignant syndrome secondary to aripiprazole initiation in a clozapine-intolerant patientAmerican Journal of Health-System Pharmacy, 2010
- Neuroleptic Malignant Syndrome Associated with Atypical Antipsychotic DrugsCNS Drugs, 2009
- The effect of lamotrigine on platelet monoamine oxidase type B activity in patients with bipolar depressionProgress in Neuro-Psychopharmacology and Biological Psychiatry, 2008
- Neuroleptic Malignant Syndrome From Aripiprazole in an Agitated Pediatric PatientClinical Neuropharmacology, 2007
- Neuroleptic malignant syndrome-like, or—dopaminergic malignant syndrome—due to levodopa therapy withdrawal. Clinical features in 11 patientsParkinsonism & Related Disorders, 2003
- Intrathecal baclofen withdrawal simulating neuroleptic malignant syndrome in a child with cerebral palsyDevelopmental Medicine & Child Neurology, 2000
- Neuroleptic malignant syndrome.Journal of Neurology, Neurosurgery & Psychiatry, 1995
- Frequency and presentation of neuroleptic malignant syndrome in a large psychiatric hospitalAmerican Journal of Psychiatry, 1986
- Practical Comprehensive Treatment of Anorexia Nervosa and BulimiaAmerican Journal of Psychiatry, 1986